ADmit Therapeutics' Incubator/Accelerator Round

ADmit Therapeutics raised a round of funding on August 09, 2018. Investors include European Institute of Innovation and Technology.

ADmit Therapeutics is a spin off from the Bellvitge Biomedical Research Institute (Barcelona, Spain) focused on the development of an early Alzheimer's disease diagnosis test.…

Articles about ADmit Therapeutics' Incubator/Accelerator Round: